Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
CLBT vs AXON vs VRNS vs OSPN vs NTCT
Revenue, margins, valuation, and 5-year total return — side by side.
Aerospace & Defense
Software - Infrastructure
Software - Infrastructure
Software - Infrastructure
CLBT vs AXON vs VRNS vs OSPN vs NTCT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Aerospace & Defense | Software - Infrastructure | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $3.38B | $34.40B | $3.37B | $455M | $2.77B |
| Revenue (TTM) | $476M | $2.98B | $660M | $246M | $861M |
| Net Income (TTM) | $78M | $206M | $-137M | $70M | $96M |
| Gross Margin | 84.2% | 59.3% | 78.1% | 70.5% | 79.2% |
| Operating Margin | 14.0% | 1.3% | -21.9% | 19.4% | 12.8% |
| Forward P/E | 37.5x | 55.0x | 242.2x | 9.9x | 15.9x |
| Total Debt | $23M | $1.91B | $572M | $6M | $76M |
| Cash & Equiv. | $124M | $1.20B | $202M | $70M | $457M |
CLBT vs AXON vs VRNS vs OSPN vs NTCT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Cellebrite DI Ltd. (CLBT) | 100 | 138.7 | +38.7% |
| Axon Enterprise, In… (AXON) | 100 | 339.6 | +239.6% |
| Varonis Systems, In… (VRNS) | 100 | 71.3 | -28.7% |
| OneSpan Inc. (OSPN) | 100 | 61.4 | -38.6% |
| NetScout Systems, I… (NTCT) | 100 | 163.5 | +63.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CLBT vs AXON vs VRNS vs OSPN vs NTCT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CLBT is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta 0.76
- Rev growth 18.6%, EPS growth 123.0%, 3Y rev CAGR 20.7%
- Lower volatility, beta 0.76, Low D/E 4.7%, current ratio 1.56x
- Beta 0.76 vs OSPN's 1.23
AXON ranks third and is worth considering specifically for long-term compounding.
- 22.0% 10Y total return vs NTCT's 66.6%
- 33.5% revenue growth vs NTCT's -0.8%
VRNS is the clearest fit if your priority is defensive.
- Beta 0.95, current ratio 1.97x
OSPN carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (9.9x vs 15.9x)
- 28.5% margin vs VRNS's -20.7%
- 3.9% yield; 2-year raise streak; the other 4 pay no meaningful dividend
- 18.9% ROA vs VRNS's -8.2%, ROIC 21.7% vs -11.0%
NTCT is the clearest fit if your priority is momentum.
- +80.5% vs VRNS's -36.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 33.5% revenue growth vs NTCT's -0.8% | |
| Value | Lower P/E (9.9x vs 15.9x) | |
| Quality / Margins | 28.5% margin vs VRNS's -20.7% | |
| Stability / Safety | Beta 0.76 vs OSPN's 1.23 | |
| Dividends | 3.9% yield; 2-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +80.5% vs VRNS's -36.7% | |
| Efficiency (ROA) | 18.9% ROA vs VRNS's -8.2%, ROIC 21.7% vs -11.0% |
CLBT vs AXON vs VRNS vs OSPN vs NTCT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CLBT vs AXON vs VRNS vs OSPN vs NTCT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
OSPN leads in 3 of 6 categories
CLBT leads 0 • AXON leads 0 • VRNS leads 0 • NTCT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CLBT and AXON and OSPN each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AXON is the larger business by revenue, generating $3.0B annually — 12.1x OSPN's $246M. OSPN is the more profitable business, keeping 28.5% of every revenue dollar as net income compared to VRNS's -20.7%. On growth, AXON holds the edge at +33.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $476M | $3.0B | $660M | $246M | $861M |
| EBITDAEarnings before interest/tax | $78M | $97M | -$135M | $57M | $171M |
| Net IncomeAfter-tax profit | $78M | $206M | -$137M | $70M | $96M |
| Free Cash FlowCash after capex | $160M | $20M | $120M | $47M | $275M |
| Gross MarginGross profit ÷ Revenue | +84.2% | +59.3% | +78.1% | +70.5% | +79.2% |
| Operating MarginEBIT ÷ Revenue | +14.0% | +1.3% | -21.9% | +19.4% | +12.8% |
| Net MarginNet income ÷ Revenue | +16.5% | +6.9% | -20.7% | +28.5% | +11.1% |
| FCF MarginFCF ÷ Revenue | +33.7% | +0.7% | +18.1% | +19.0% | +32.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.1% | +33.7% | +26.9% | +4.1% | -0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +89.8% | 0.0% | -18.9% | +11.9% |
Valuation Metrics
OSPN leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 6.4x trailing earnings, OSPN trades at a 98% valuation discount to AXON's 282.7x P/E. On an enterprise value basis, OSPN's 6.0x EV/EBITDA is more attractive than AXON's 1664.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.4B | $34.4B | $3.4B | $455M | $2.8B |
| Enterprise ValueMkt cap + debt − cash | $3.3B | $35.1B | $3.7B | $391M | $2.4B |
| Trailing P/EPrice ÷ TTM EPS | 44.55x | 282.71x | -25.38x | 6.39x | -7.57x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.53x | 54.97x | 242.23x | 9.89x | 15.87x |
| PEG RatioP/E ÷ EPS growth rate | 0.76x | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 41.79x | 1664.88x | — | 6.00x | — |
| Price / SalesMarket cap ÷ Revenue | 7.10x | 12.37x | 5.40x | 1.87x | 3.36x |
| Price / BookPrice ÷ Book value/share | 7.13x | 13.16x | 6.19x | 1.72x | 1.78x |
| Price / FCFMarket cap ÷ FCF | 21.06x | 458.11x | 24.99x | 9.02x | 13.11x |
Profitability & Efficiency
OSPN leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
OSPN delivers a 27.3% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $-27 for VRNS. OSPN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRNS's 0.96x. On the Piotroski fundamental quality scale (0–9), AXON scores 6/9 vs CLBT's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.2% | +6.6% | -27.4% | +27.3% | +6.1% |
| ROA (TTM)Return on assets | +8.3% | +3.1% | -8.2% | +18.9% | +4.3% |
| ROICReturn on invested capital | +18.5% | -1.3% | -11.0% | +21.7% | -19.3% |
| ROCEReturn on capital employed | +13.8% | -1.5% | -14.0% | +19.6% | -18.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.05x | 0.59x | 0.96x | 0.02x | 0.05x |
| Net DebtTotal debt minus cash | -$102M | $709M | $369M | -$64M | -$381M |
| Cash & Equiv.Liquid assets | $124M | $1.2B | $202M | $70M | $457M |
| Total DebtShort + long-term debt | $23M | $1.9B | $572M | $6M | $76M |
| Interest CoverageEBIT ÷ Interest expense | — | 1.18x | -9.01x | 1656.95x | 55.89x |
Total Returns (Dividends Reinvested)
Evenly matched — CLBT and AXON and NTCT each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AXON five years ago would be worth $31,683 today (with dividends reinvested), compared to $4,969 for OSPN. Over the past 12 months, NTCT leads with a +80.5% total return vs VRNS's -36.7%. The 3-year compound annual growth rate (CAGR) favors CLBT at 36.3% vs OSPN's -2.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -22.6% | -24.2% | -10.5% | -0.1% | +42.6% |
| 1-Year ReturnPast 12 months | -27.6% | -29.1% | -36.7% | -19.1% | +80.5% |
| 3-Year ReturnCumulative with dividends | +153.4% | +92.4% | +23.7% | -7.0% | +30.3% |
| 5-Year ReturnCumulative with dividends | +39.9% | +216.8% | -39.9% | -50.3% | +42.9% |
| 10-Year ReturnCumulative with dividends | +43.0% | +2200.0% | +317.5% | -21.7% | +66.6% |
| CAGR (3Y)Annualised 3-year return | +36.3% | +24.4% | +7.3% | -2.4% | +9.2% |
Risk & Volatility
Evenly matched — CLBT and NTCT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CLBT is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than OSPN's 1.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NTCT currently trades 97.6% from its 52-week high vs VRNS's 44.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 1.19x | 0.95x | 1.23x | 1.12x |
| 52-Week HighHighest price in past year | $20.45 | $885.92 | $63.90 | $18.13 | $39.24 |
| 52-Week LowLowest price in past year | $11.02 | $339.01 | $19.70 | $10.07 | $19.98 |
| % of 52W HighCurrent price vs 52-week peak | +67.5% | +48.2% | +44.9% | +67.0% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 40.5 | 66.1 | 61.5 | 68.6 |
| Avg Volume (50D)Average daily shares traded | 1.7M | 1.0M | 2.3M | 599K | 552K |
Analyst Outlook
OSPN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: CLBT as "Buy", AXON as "Buy", VRNS as "Buy", OSPN as "Buy", NTCT as "Hold". Consensus price targets imply 70.2% upside for AXON (target: $727) vs -24.3% for NTCT (target: $29). OSPN is the only dividend payer here at 3.95% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $20.67 | $726.71 | $36.00 | $15.50 | $29.00 |
| # AnalystsCovering analysts | 8 | 21 | 34 | 15 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +3.9% | — |
| Dividend StreakConsecutive years of raises | 1 | — | — | 2 | — |
| Dividend / ShareAnnual DPS | — | — | — | $0.48 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.4% | +2.9% | +0.9% |
OSPN leads in 3 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 3 categories are tied.
CLBT vs AXON vs VRNS vs OSPN vs NTCT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CLBT or AXON or VRNS or OSPN or NTCT a better buy right now?
For growth investors, Axon Enterprise, Inc.
(AXON) is the stronger pick with 33. 5% revenue growth year-over-year, versus -0. 8% for NetScout Systems, Inc. (NTCT). OneSpan Inc. (OSPN) offers the better valuation at 6. 4x trailing P/E (9. 9x forward), making it the more compelling value choice. Analysts rate Cellebrite DI Ltd. (CLBT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CLBT or AXON or VRNS or OSPN or NTCT?
On trailing P/E, OneSpan Inc.
(OSPN) is the cheapest at 6. 4x versus Axon Enterprise, Inc. at 282. 7x. On forward P/E, OneSpan Inc. is actually cheaper at 9. 9x.
03Which is the better long-term investment — CLBT or AXON or VRNS or OSPN or NTCT?
Over the past 5 years, Axon Enterprise, Inc.
(AXON) delivered a total return of +216. 8%, compared to -50. 3% for OneSpan Inc. (OSPN). Over 10 years, the gap is even starker: AXON returned +22. 0% versus OSPN's -21. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CLBT or AXON or VRNS or OSPN or NTCT?
By beta (market sensitivity over 5 years), Cellebrite DI Ltd.
(CLBT) is the lower-risk stock at 0. 76β versus OneSpan Inc. 's 1. 23β — meaning OSPN is approximately 62% more volatile than CLBT relative to the S&P 500. On balance sheet safety, OneSpan Inc. (OSPN) carries a lower debt/equity ratio of 2% versus 96% for Varonis Systems, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CLBT or AXON or VRNS or OSPN or NTCT?
By revenue growth (latest reported year), Axon Enterprise, Inc.
(AXON) is pulling ahead at 33. 5% versus -0. 8% for NetScout Systems, Inc. (NTCT). On earnings-per-share growth, the picture is similar: Cellebrite DI Ltd. grew EPS 123. 0% year-over-year, compared to -144. 4% for NetScout Systems, Inc.. Over a 3-year CAGR, AXON leads at 32. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CLBT or AXON or VRNS or OSPN or NTCT?
OneSpan Inc.
(OSPN) is the more profitable company, earning 30. 0% net margin versus -44. 6% for NetScout Systems, Inc. — meaning it keeps 30. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OSPN leads at 20. 6% versus -44. 7% for NTCT. At the gross margin level — before operating expenses — CLBT leads at 84. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CLBT or AXON or VRNS or OSPN or NTCT more undervalued right now?
On forward earnings alone, OneSpan Inc.
(OSPN) trades at 9. 9x forward P/E versus 242. 2x for Varonis Systems, Inc. — 232. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AXON: 70. 2% to $726. 71.
08Which pays a better dividend — CLBT or AXON or VRNS or OSPN or NTCT?
In this comparison, OSPN (3.
9% yield) pays a dividend. CLBT, AXON, VRNS, NTCT do not pay a meaningful dividend and should not be held primarily for income.
09Is CLBT or AXON or VRNS or OSPN or NTCT better for a retirement portfolio?
For long-horizon retirement investors, OneSpan Inc.
(OSPN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 23), 3. 9% yield). Both have compounded well over 10 years (OSPN: -21. 7%, AXON: +22. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CLBT and AXON and VRNS and OSPN and NTCT?
These companies operate in different sectors (CLBT (Technology) and AXON (Industrials) and VRNS (Technology) and OSPN (Technology) and NTCT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CLBT is a small-cap high-growth stock; AXON is a mid-cap high-growth stock; VRNS is a small-cap quality compounder stock; OSPN is a small-cap deep-value stock; NTCT is a small-cap quality compounder stock. OSPN pays a dividend while CLBT, AXON, VRNS, NTCT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.